How big is the Latin America Diabetes Care Drugs Market?

The Latin America Diabetes Care Drugs Market size is expected to reach USD 4.71 billion in 2024 and grow at a CAGR of 3.48% to reach USD 5.58 billion by 2029. Read More

What is the current Latin America Diabetes Care Drugs Market size?

In 2024, the Latin America Diabetes Care Drugs Market size is expected to reach USD 4.71 billion. Read More

Who are the key players in Latin America Diabetes Care Drugs Market?

Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca and Boehringer Ingelheim are the major companies operating in the Latin America Diabetes Care Drugs Market. Read More

What years does this Latin America Diabetes Care Drugs Market cover, and what was the market size in 2023?

In 2023, the Latin America Diabetes Care Drugs Market size was estimated at USD 4.55 billion. The report covers the Latin America Diabetes Care Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Latin America Diabetes Care Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Latin America Diabetes Care Drugs Market Share

Statistics for the 2023 & 2024 Latin America Diabetes Care Drugs market share, created by Mordor Intelligence™ Industry Reports. Latin America Diabetes Care Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Latin America Diabetes Care Drugs Industry

The Latin American diabetes care drugs market includes several established global and local players. In Latin America, only a few players significantly share the need for branded drugs. However, the number of players for generic drugs is high, including several local ones. Novo Nordisk holds the largest share in the Latin American diabetes care drug market. Branded drugs from Eli Lilly and Boehringer Ingelheim Alliance are expected to record a high CAGR of more than 15% in the forecast period.